VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $19,204,000 | +13.6% | 826,315 | -22.2% | 0.01% | 0.0% |
Q1 2018 | $16,911,000 | -33.2% | 1,062,257 | -12.9% | 0.01% | -33.3% |
Q4 2017 | $25,334,000 | +23.3% | 1,219,163 | -15.0% | 0.01% | +12.5% |
Q3 2017 | $20,549,000 | -30.3% | 1,433,921 | -15.9% | 0.01% | -11.1% |
Q2 2017 | $29,499,000 | +26.5% | 1,705,131 | -19.3% | 0.01% | +12.5% |
Q1 2017 | $23,313,000 | +2649.2% | 2,113,542 | +3516.3% | 0.01% | – |
Q4 2016 | $848,000 | -49.0% | 58,445 | -13.8% | 0.00% | -100.0% |
Q3 2016 | $1,664,000 | +15.9% | 67,779 | -4.9% | 0.00% | 0.0% |
Q2 2016 | $1,436,000 | -29.5% | 71,293 | -8.1% | 0.00% | 0.0% |
Q1 2016 | $2,038,000 | -80.4% | 77,545 | -24.1% | 0.00% | -75.0% |
Q4 2015 | $10,385,000 | -42.5% | 102,158 | +0.9% | 0.00% | -50.0% |
Q3 2015 | $18,063,000 | -37.8% | 101,270 | -22.5% | 0.01% | -27.3% |
Q2 2015 | $29,030,000 | +4.2% | 130,687 | -7.3% | 0.01% | 0.0% |
Q1 2015 | $27,858,000 | +14.6% | 140,973 | -17.0% | 0.01% | +22.2% |
Q4 2014 | $24,302,000 | +59.3% | 169,802 | +46.1% | 0.01% | +50.0% |
Q3 2014 | $15,253,000 | +2.7% | 116,188 | -1.0% | 0.01% | 0.0% |
Q2 2014 | $14,859,000 | -52.4% | 117,364 | -50.4% | 0.01% | -53.8% |
Q1 2014 | $31,207,000 | -14.9% | 236,801 | -24.3% | 0.01% | -13.3% |
Q4 2013 | $36,679,000 | -0.8% | 312,706 | -11.6% | 0.02% | -6.2% |
Q3 2013 | $36,958,000 | +4.6% | 353,932 | -13.8% | 0.02% | 0.0% |
Q2 2013 | $35,317,000 | – | 410,536 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |